,

–

Garin, M.-C., James, R.W., Dussoix, P., Blanche, H., Passa, P., Froguel, P., Ruiz, J.l.,

Paraoxonase polymoprhism Met-Leu

is associated with modified serum concentrations of the enzyme. J. Clin. Invest.

,

–

Gledmacher, V., Mallinckrodt, M., Diepgen, T.L.,

The human paraoxonase polymorphism and specificity. Toxicol. Environ. Chem.

,

–

Hasselwander, O., Savage, D.A., M

aster, D., Loughrey, C.M., M

amee, P.T., Middleton, D., Nicholls, D.P., Maxwell, A.P., Young, I.S.,

Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients. Kid. Int.

,

–

References

important in order to maximise the quality of life of elderly people. Longevity is a complex trait, resulting from the interaction between multiple genetic and environmental factors. At the beginning of this study we had hypothesised that the192R allele, in view of its association with CHD, would be less frequent in very elderly survivors such as centenarians and nonagenarians compared to younger control populations. However, contra-intuitively we found that the 192R allele frequency was modestly enriched in the oldest survivors and that there was no sex-specific influence, which seemed to argue against a cardiovascular-related mechanism of effect. The192R allele is associated with high PON activity, using paraoxon as substrate and it may be that this allele does afford additional protection against various environmental toxins or damaging oxidative stress situ- ations. It is well recognised that association studies may be subject to spurious results, particularly because of small numbers of cases and controls, lack of an appropriate control group, poorly defined phenotype, and population admixture. We believe that these issues are less important in our study as the findings appear similar across two European countries and the number of subjects in the very oldest cohort and their control groups is large. An alternative explanation is that the 192R allele is in linkage disequilibrium with a functional neighbouring gene awaiting identification. Further work will be required to elucidate more precisely the role of paraoxonase in human biology and to see if our findings can be replicated in other independent populations or in a

Norther

relan

oun

eart

roject.Int.J.Sport

ed.

(Suppl.

), S

–S

Bub, A., Barth, S., Watzl, B., Briviba, K., Herbert, B.M., Luhrmann, P.M., Neuhauser-Berthoh, J., Rechkemmer, G.,

Paraxonase

Q-

polymorphism is associated with reduced lipid peroxidation in R-allele- carrier but not in QQ homozygous elderly subjects on a tomato-rich diet. Eur. J. Nutr.

,

–

Davies, H.G., Richter, R.J., Keifer, M., Broomfield, C.A., Sowalla, J., Furlong, C.E.,

The effect of the human serum paraoxonase polymoprhism is reversed with diaoxon, soman and sarin. Nat. Genet.

,

–

Durrington, P.N., Mackness, B., Mackness, M.I.,

The hunt for nutritional and pharmacological modulators of Paraxonase. Atheros- cler. Thromb. Vasc. Biol.

,

–

Frisoni, G.B., Louhija, J., Geroldi, C., Trabucchi, M.,

Longevity and the epsilon

allele of apolipoprotein E: the Finnish Centenarians Study. J. Gerontol. A Biol. Sci. Med. Sci.

, M

–M

Fuhrman, B., Aviram, M.,

Preservation of paraoxonase activity by wine flavonoids: possible role in protection of LDL from lipid peroxidation. Ann. NY Acad. Sci.

,

–

Garin, M.-C., James, R.W., Dussoix, P., Blanche, H., Passa, P., Froguel, P., Ruiz, J.l.,

Paraoxonase polymoprhism Met-Leu

is associated with modified serum concentrations of the enzyme. J. Clin. Invest.

,

–

Gledmacher, V., Mallinckrodt, M., Diepgen, T.L.,

The human paraoxonase polymorphism and specificity. Toxicol. Environ. Chem.

,

–

Hasselwander, O., Savage, D.A., M

aster, D., Loughrey, C.M., M

amee, P.T., Middleton, D., Nicholls, D.P., Maxwell, A.P., Young, I.S.,

Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients. Kid. Int.

,

–

Acknowledgements

Dr Rea thanks General Practitioner colleagues, the patients and Ms Anne Murphy, research nurse for dedicated work in the community.

I.M. Rea et al. / Experimental Gerontology 39 (2004) 629–635

Miller, S.A., Dykes, D.D., Polesky, H.F.,

A simple procedure for extracting DNA from human nucleated cells. Nucl. Res.

,

Muiras, M.-L., Verasdonck, P., Cottet, F., Scha¨chter, F.,

Lack association between human longevity and genetic polymorphisms drug-metabolizing enzymes at the NAT

, GSTM

and CYP

D

Hum. Genet.

,

–

Playfer, J.R., Powell, C., Evans, D.A.,

Plasma paroxonase activity old age. Age Ageing

,

–

Primo-Parmo, S.L., Sorensen, R.C., Teiber, J., La Du, B.N.,

human serum paraoxonase/arylesterase gene (PON

) is one member a multigene family. Genomics

,

–

Rea, I.M., M

aster, D., Woodside, J.V., Young, I.S., Archbold, Linton, T., Lennox, S., M

ulty, H., Harmon, D.L., Whitehead,

Community-living nonagenarians in Northern Ireland have plasma homocysteine but similar methylenetetrahydrofolate thermolabile genotype prevalence compared to

-

-year-old Atherosclerosis

,

–

Rea, I.M., Mc Dowell, I., M

aster, D., Smye, M., Stout, R., Evans,

MONICA group (Belfast), monitoring of cardiovascular study group. Apolipoprotein E alleles in nonagenarian subjects in Belfast Elderly Longitudinal Free-living Ageing Study Mech. Ageing Dev.

,

–

Ruiz, J., Blanche´, H., James, R.W., Garin, M.C., Vaisse, C., G., Cohen, N., Morabia, A., Passa, P., Froguel, P.,

polymorphism of paraoxonase and coronary heart disease in type diabetes. Lancet

,

–

Salonen, J.T., Malin, R., Tuomainen, T-P., Nyysso¨nen, K., Lakka, Lehtima¨ki, T.,

Polymorphism in high density paraoxonase gene and risk of acute myocardial infarction in prospective nested case-control study. BMJ

,

–

Sanghera, D.K., Saha, N., Aston, C.E., Kamboh, M.I.,

polymorphism of paraoxonase and the risk of coronary heart Arterioscler. Thromb. Vasc. Biol.

,

–

Sanghera, D.K., Aston, C.E., Saha, N., Kamboh, M.I.,